EPISODE · Apr 21, 2026 · 27 MIN
On the road to early detection: Inside icare’s Lung Bus and its mission to protect NSW workers
from Dust Disease Diaries: Real lives, real stories of asbestos & beyond
In this episode of Dust Disease Diaries, we’re joined by Milly Heinnen, Head of Health Screening, Dust Diseases Care at icare, who shares how mobile lung health screening – the icare Lung Bus - is helping protect workers across NSW from asbestos and silica-related diseases. Milly explains the role of the Dust Diseases Care Scheme, how the new state-of-the-art Lung Bus launched in February 2025 is expanding access to free screening, and what workers can expect during the process - from X-rays and lung function tests to specialist review and follow‑up. She discusses why early detection is critical, how data is used to target high‑risk regions and industries, common concerns workers and employers have about screening, and how flexible service models and emerging technologies like AI could shape the future of lung health monitoring across the state. Milly Heinnen is Head of Health Screening for the Dust Disease Care (DDC), and is dedicated to increasing awareness of the importance of health screenings for dust-related diseases across NSW. In this position, she leads efforts to enhance screening services for at-risk workers, innovate work methods, and partner with stakeholders to create an impact for those affected. Through this role, she aims to make a significant impact on public health by enhancing the visibility of dust disease screenings and ultimately improving health outcomes for those affected. By raising awareness and providing accessible screening options, we can empower individuals to take charge of their health.You can find out more about the icare Lung Bus here. To find out more about ADDRI, visit our website.Thank you to our Podcast Interviewer and host James O’Loghlin and Producer Rod Morri from Sydney Podcast Studios.If you have any questions or comments, please email [email protected]
What this episode covers
In this episode of Dust Disease Diaries, we’re joined by Milly Heinnen, Head of Health Screening, Dust Diseases Care at icare, who shares how mobile lung health screening – the icare Lung Bus - is helping protect workers across NSW from asbestos and silica-related diseases. Milly explains the role of the Dust Diseases Care Scheme, how the new state-of-the-art Lung Bus launched in February 2025 is expanding access to free screening, and what workers can expect during the process - from X-rays and lung function tests to specialist review and follow‑up. She discusses why early detection is critical, how data is used to target high‑risk regions and industries, common concerns workers and employers have about screening, and how flexible service models and emerging technologies like AI could shape the future of lung health monitoring across the state. Milly Heinnen is Head of Health Screening for the Dust Disease Care (DDC), and is dedicated to increasing awareness of the importance of health screenings for dust-related diseases across NSW. In this position, she leads efforts to enhance screening services for at-risk workers, innovate work methods, and partner with stakeholders to create an impact for those affected. Through this role, she aims to make a significant impact on public health by enhancing the visibility of dust disease screenings and ultimately improving health outcomes for those affected. By raising awareness and providing accessible screening options, we can empower individuals to take charge of their health.You can find out more about the icare Lung Bus here. To find out more about ADDRI, visit our website.Thank you to our Podcast Interviewer and host James O’Loghlin and Producer Rod Morri from Sydney Podcast Studios.If you have any questions or comments, please email [email protected]
NOW PLAYING
On the road to early detection: Inside icare’s Lung Bus and its mission to protect NSW workers
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m